Sustainability means more than reducing our footprint. At CSL, it also means expanding access to our therapies, supporting community health programs and partnering with organizations that improve care for those who need it most. Providing better care for brighter days ahead. #PromisingFutures #CSL Join us: https://bit.ly/4knsnnP
Hear from Patients Who Rely on Plasma-Based Medicines
We share a TV news report about a mother and son who have a primary immune deficiency (PI).
CSL's 2025 Half Year Financial Results Click here for Full Information including Webcast Recording → | Would you like to read our 2024 Annual Report? Click here to view or download the Annual Report →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL Behring
CSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL Seqirus
CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: A CSL employee in Bern, Switzerland
3 Jul
💡 What if a congress booth could help change the world? At CSL Vifor, we believe every step matters — and that includes how we show up at congresses. This year at ERA, we were proud to be recognized as part of the association’s first-ever Green Meeting Certificate. It’s a clear signal that sustainability is becoming a shared priority across the industry. Our contribution? ✔️ A sustainable, modular, and reusable booth ✔️ A no-paper approach — everything available via QR code ✔️ A mindset of “not built to be destroyed” It’s all part of our long-term strategy to make kidney care — and the planet — better, one step at a time. 👉 Driven by our promise to improve kidney care, we’re committed to rethinking not just treatments, but how we engage. #SustainabilityInAction #CSLVifor #ERA2025 #GreenMeetings #OneStepAtATime #KidneyCare
2 Jul